Table 1 Skp2 expression and Clinicopathological characteristics for entire cohort of patients

Age(years)

≤60

96

50 (52.1)

46 (47.9)

0.144

>60

61

39 (63.9)

22 (36.1)

Gender

Male

126

69 (54.8)

57 (45.2)

0.326

Female

31

20 (64.5)

11 (35.5)

Tumor location

Upper

20

12 (60.0)

8 (40.0)

0.796

Middle

76

41 (53.9)

35 (46.1)

Lower

61

36 (59.0)

25 (41.0)

Cell differentiation

G1

27

15 (55.6)

12 (44.4)

0.861

G2

80

47 (58.8)

33 (41.2)

G3

50

27 (54.0)

23 (46.0)

Pathological T status

T1

15

11 (73.3)

4 (26.7)

0.035

T2

42

29 (69.0)

13 (31.0)

*T3-4

100

49 (49.0)

51 (51.0)

Pathological N status

N0

87

52 (59.8)

35 (40.2)

0.438

N1

46

27 (58.7)

19 (41.3)

N2

21

9 (42.9)

12 (57.1)

N3

3

1 (33.3)

2 (66.7)

AJCC stage

I

37

28 (75.7)

9 (24.3)

0.027

II

65

34 (52.3)

31 (47.7)

III

55

27 (49.1)

28 (50.9)

Overall

157

89 (56.7)

68 (43.3)

—